Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant
International Ophthalmology · 2026
DOI: 10.1007/s10792-026-04262-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Ophthalmology, 2026. Verfasst von Susana Penas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology of ULS São João, Porto, Portugal. up391035@up.pt. Hauptthemen laut MEDLINE: Fluocinolone Acetonide, Macular Edema, Diabetic Retinopathy, Visual Acuity. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: This study aimed to assess the effectiveness of 0.19-mg fluocinolone acetonide intravitreal (FAc) implant to control retinal thickness fluctuations (RTF) in diabetic macular edema (DME) and its effect on best-corrected visual acuity (BCVA). METHODS: The RIVER study was a multicenter, retrospective, non-interventional study analyzing data of the Retina.pt portuguese national registry in DME. Retinal thickness was assessed using the spectral domain optical coherence tomography (SD-OCT). The primary endpoint was the assessment of RTF along the follow-up, through the combined measurement of retinal thickness amplitude (RTA), retinal thickness standard deviation (RTSD), and central subfield thickness area under the curve (CST-AUC). Eyes were stratified into quartiles (Q) and median-split according to these variables. RESULTS: The mean follow-up time after the FAc implantation was 82 ± 26, 96 months. From baseline to last follow-up visit after the implant, mean RTA decreased from 187.6±150.4 to 151.6±126.4 µm (p=0.1204), mean RTSD significantly reduced from 96.3±78.1 to 60.8±57.3 µm (p=0.0032) and mean CST-AUC significantly reduced from 446 to 349 µm (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology of ULS São João, Porto, Portugal. up391035@up.pt.
- Faculty of Medicine, University of Porto, Porto, Portugal. up391035@up.pt.
- Department of Ophthalmology, ULS São João, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. up391035@up.pt.
- Diabetes Ocular Department of Centro Hospitalar e Universitário de Santo António (CHUdSA), Porto, Portugal.
- Department of Ophthalmology, Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute for the Biomedical Sciences Abel Salazar From University of Porto (UMIB ICBAS - UP), Porto, Portugal.
- Department of Ophthalmology of Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Porto, Portugal.
Zitieren
APA
Penas, S., Pessoa, B., Teixeira, C., Ruão, M., Sousa, J. P. C., Carneiro, Â., Silva, R., & Meireles, A. (2026). Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant. International Ophthalmology. https://doi.org/10.1007/s10792-026-04262-w
Vancouver
Penas S, Pessoa B, Teixeira C, Ruão M, Sousa JPC, Carneiro Â, et al. Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant. International Ophthalmology. 2026. doi:10.1007/s10792-026-04262-w
BibTeX
@article{Penas2026,
author = {Penas, Susana and Pessoa, Bernardete and Teixeira, Carla and Ruão, Miguel and Sousa, João Paulo Castro and Carneiro, Ângela and Silva, Rufino and Meireles, Angelina},
title = {Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant},
journal = {International Ophthalmology},
year = {2026},
doi = {10.1007/s10792-026-04262-w}
}
EUVIMED